If RELTfms can serve as a therapeutic target to increase the killing of BC cells, we predict that RELT and RELL2 would serve as better targets due to their increased ability to kill BC cells (Figure 3 and Figure 4) and the previously reported ability of RELL2 to inhibit the migration and invasion of BC cell lines [57]. The gene discussed is RELL2; the disease is breast cancer.